Trademark: 86300715
Word
ATGEN
Status
Dead
Status Code
604
Status Date
Tuesday, February 5, 2019
Serial Number
86300715
Mark Type
3000
Filing Date
Wednesday, June 4, 2014
Published for Opposition
Tuesday, May 26, 2015
Abandoned Date
Tuesday, February 5, 2019

Trademark Owner History
ATGen Co., Ltd. - Owner At Publication

Classifications
1 Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
5 Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
35 Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
40 Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
42 medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
Color is not claimed as a feature of the mark.
The mark consists of a double helix spanning horizontally above the word "ATGen" in front of two concentric circles.
AT GEN

Trademark Events
Feb 5, 2019
Abandonment Notice E-Mailed - Inter Partes Decision
Feb 5, 2019
Abandonment - After Inter Partes Decision
Feb 5, 2019
Opposition Terminated No. 999999
Feb 5, 2019
Opposition Dismissed No. 999999
Dec 2, 2016
Teas Change Of Correspondence Received
Sep 22, 2015
Opposition Instituted No. 999999
Jun 22, 2015
Extension Of Time To Oppose Received
May 26, 2015
Official Gazette Publication Confirmation E-Mailed
May 26, 2015
Published For Opposition
May 6, 2015
Notification Of Notice Of Publication E-Mailed
Apr 17, 2015
Law Office Publication Review Completed
Apr 14, 2015
Approved For Pub - Principal Register
Mar 19, 2015
Teas/Email Correspondence Entered
Mar 19, 2015
Correspondence Received In Law Office
Mar 12, 2015
Assigned To Lie
Mar 4, 2015
Teas Response To Office Action Received
Sep 22, 2014
Notification Of Non-Final Action E-Mailed
Sep 22, 2014
Non-Final Action E-Mailed
Sep 22, 2014
Non-Final Action Written
Sep 16, 2014
Assigned To Examiner
Jun 18, 2014
Notice Of Design Search Code E-Mailed
Jun 17, 2014
New Application Office Supplied Data Entered In Tram
Jun 7, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24